Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Legend Biotech Corp as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 208
- −2 vs. Q4 2024
- Shares held
- 86.6M
- −12.6M (−12.7%) vs. Q4 2024
- Total value
- $2.91B
- −$320.4M (−9.9%) vs. Q4 2024
- New holders
- 29
- 75 more added
- Sold out
- 31
- 80 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $2.98B |
| Q1 2026 | 190 | $1.74B |
| Q4 2025 | 200 | $1.90B |
| Q3 2025 | 200 | $2.73B |
| Q2 2025 | 211 | $3.00B |
| Q1 2025 | 208 | $2.91B |
| Q4 2024 | 211 | $3.23B |
| Q3 2024 | 208 | $4.44B |
| Q2 2024 | 181 | $4.06B |
| Q1 2024 | 192 | $4.85B |
| Q4 2023 | 206 | $5.16B |
| Q3 2023 | 200 | $5.78B |
| Q2 2023 | 194 | $5.81B |
| Q1 2023 | 160 | $3.28B |
| Q4 2022 | 170 | $3.18B |
| Q3 2022 | 159 | $2.60B |
| Q2 2022 | 151 | $2.90B |
| Q1 2022 | 141 | $1.85B |
| Q4 2021 | 139 | $2.34B |
| Q3 2021 | 88 | $1.97B |
| Q2 2021 | 86 | $1.16B |
| Q1 2021 | 71 | $765.9M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Legend Biotech Corp; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 2,936,703 | $99.6M | 0.02% | −373,268−11.3% | Reduced |
| Braidwell LP | 2,977,951 | $101.0M | 3.55% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,749,965 | $127.2M | 5.15% | +253,731+7.3% | Added |
| BlackRock, Inc. | 4,527,000 | $153.6M | 0.00% | −81,452−1.8% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 5,984,550 | $203.1M | 5.74% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 6,729,779 | $228.3M | 0.03% | −78,302−1.2% | Reduced |
| Westfield Capital Management Co LP | 6,917,567 | $234.7M | 1.14% | +1,203,871+21.1% | Added |
| FMR LLC | 13,204,213 | $448.0M | 0.03% | −242,799−1.8% | Reduced |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −7,506,934−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −475,000−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −388,704−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Tiger Pacific Capital LP | 0 | $0 | 0.00% | −222,000−100.0% | Sold out |
| Springhill Fund Asset Management (HK) Co Ltd | 0 | $0 | 0.00% | −190,800−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −73,168−100.0% | Sold out |
| Exane Asset Management | 0 | $0 | 0.00% | −67,782−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −67,200−100.0% | Sold out |
| Sector Gamma AS | 0 | $0 | 0.00% | −48,495−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −42,575−100.0% | Sold out |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −38,466−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −37,600−100.0% | Sold out |
| Maso Capital Partners Ltd | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −20,669−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −17,464−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −15,927−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −11,935−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −9,852−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −7,826−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −7,614−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −7,600−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −7,363−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −7,324−100.0% | Sold out |
| TimesSquare Capital Management, LLC | 0 | $0 | 0.00% | −2,912−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −297−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bryn Mawr Trust Co | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Abound Wealth Management | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |